Knockdown of orexin type 2 receptor in the lateral pontomesencephalic tegmentum of rats increases REM sleep
- PMID: 23282008
- PMCID: PMC3604039
- DOI: 10.1111/ejn.12101
Knockdown of orexin type 2 receptor in the lateral pontomesencephalic tegmentum of rats increases REM sleep
Abstract
Dysfunction of the orexin/hypocretin neurotransmitter system causes the sleep disorder narcolepsy, characterized by intrusion of rapid eye movement (REM) sleep-like events into normal wakefulness. The sites where orexins act to suppress REM sleep are incompletely understood. Previous studies suggested that the lateral pontomesencephalic tegmentum (lPMT) contains an important REM sleep inhibitory area, and proposed that orexins inhibit REM sleep via orexin type 2 receptors (OxR2) in this region. However, this hypothesis has heretofore not been tested. We thus performed bilateral injection of small interfering RNAs (siRNAs) targeting Ox2R into the lPMT on two consecutive days. This led to a approximately 30% increase of time spent in REM sleep in both the dark and light periods for the first 2 days after injection, with a return to baseline over the next two post-injection days. This increase was mainly due to longer (> 120 s) REM episodes. Cataplexy-like episodes were not observed. The percentage of time spent in wakefulness and non-(N)REM sleep, as well as the power spectral profile of NREM and REM sleep, were unaffected. Control animals injected with scrambled siRNA had no sleep changes post-injection. Quantification of the knockdown revealed that unilateral microinjection of siRNAs targeting OxR2 into the lPMT induced a approximately 40% reduction of OxR2 mRNA 2 days following the injections when compared with the contralateral side receiving control (scrambled) siRNA. Orexin type 1 receptor mRNA level was unaffected. Our results indicate that removal of OxR2 neurotransmission in the lPMT enhances REM sleep by increasing the duration of REM episodes.
Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Similar articles
-
Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period.Eur J Neurosci. 2010 Nov;32(9):1528-36. doi: 10.1111/j.1460-9568.2010.07401.x. Eur J Neurosci. 2010. PMID: 21089218 Free PMC article.
-
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.Neuron. 2003 Jun 5;38(5):715-30. doi: 10.1016/s0896-6273(03)00330-1. Neuron. 2003. PMID: 12797957
-
REM sleep changes in rats induced by siRNA-mediated orexin knockdown.Eur J Neurosci. 2006 Oct;24(7):2039-48. doi: 10.1111/j.1460-9568.2006.05058.x. Eur J Neurosci. 2006. PMID: 17067300 Free PMC article.
-
Cell transplantation: a future therapy for narcolepsy?CNS Neurol Disord Drug Targets. 2009 Aug;8(4):309-14. doi: 10.2174/187152709788921681. CNS Neurol Disord Drug Targets. 2009. PMID: 19689312 Review.
-
Sleep, sleep disorders and hypocretin (orexin).Sleep Med. 2004 Jun;5 Suppl 1:S2-8. doi: 10.1016/s1389-9457(04)90001-9. Sleep Med. 2004. PMID: 15301991 Review.
Cited by
-
Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.Neuropsychopharmacology. 2018 Nov;43(12):2373-2382. doi: 10.1038/s41386-018-0054-4. Epub 2018 Apr 6. Neuropsychopharmacology. 2018. PMID: 29703996 Free PMC article.
-
Orexin OX2 Receptor Antagonists as Sleep Aids.Curr Top Behav Neurosci. 2017;33:105-136. doi: 10.1007/7854_2016_47. Curr Top Behav Neurosci. 2017. PMID: 27909987 Review.
-
Distinct effects of IPSU and suvorexant on mouse sleep architecture.Front Neurosci. 2013 Dec 10;7:235. doi: 10.3389/fnins.2013.00235. eCollection 2013. Front Neurosci. 2013. PMID: 24368893 Free PMC article.
-
Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep.eNeuro. 2016 Mar 21;3(2):ENEURO.0018-16.2016. doi: 10.1523/ENEURO.0018-16.2016. eCollection 2016 Mar-Apr. eNeuro. 2016. PMID: 27022631 Free PMC article.
References
-
- Boissard R, Fort P, Gervasoni D, Barbagli B, Luppi PH. Localization of the GABAergic and non-GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset. Eur. J. Neurosci. 2003;18:1627–1639. - PubMed
-
- Brischoux F, Mainville L, Jones BE. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J. Comp. Neurol. 2008;510:607–630. - PubMed
-
- Brown RE. Involvement of hypocretins/orexins in sleep disorders and narcolepsy. Drug News. Perspect. 2003;16:75–79. - PubMed
-
- Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell. 1999;98:437–451. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources